Breakfast Seminar Series

LOCATION: Center for BioHealth Building, Room CBH-230
UNT Health Science Center
3400 Camp Bowie Blvd. Fort Worth, TX 76107

November 19, 2009
7:30 - 9:00 a.m.

Debra Wawro, CEO, Resonant Sensors Incorporated (RSI), will be November's speaker at the BIODFW Breakfast Seminar Series, held at the University of North Texas Health Science Center at Fort Worth.

In December 2004, Resonant Sensors Incorporated (RSI) was founded by Debra Wawro and Dr. Robert Magnusson, the Texas Instruments Distinguished University Chair in Nanoelectronics at the University of Texas at Arlington. The company was formed in partnership with the University of Texas at Arlington to commercialize technologies invented and developed by Ms. Wawro and Dr. Magnusson.

Debra Wawro CEO, Resonant Sensors Inc.

Prior to founding RSI, Ms. Wawro held Operations/Commodity Management and R&D Management positions at Marconi Networks and Tellabs. She also led a research lab analyzing and developing drug delivery methods for chemotherapeutic agents at the University of Texas Southwestern Medical Center at Dallas.  She holds an MS EE from UT Arlington, and has several pending and issued patents.

In addition to successfully raising capital from private investors, RSI has been awarded funding from the Texas Emerging Technology fund. RSI is also the recipient of multiple SBIR awards from the NSF and NIH. RSI was awarded a U.S. Department of Commerce "Recognition of Excellence in Innovation" certificate on August 9, 2007.

RSI is developing a new optical sensor technology that can monitor biochemical reactions in real time, with outstanding accuracy and without the need for chemical tags. This differentiating technology will provide new tools for the biosensor market that will dramatically reduce the cost and development time of pharmaceutical and medical products. The heart of the sensor technology is the guided-mode resonance effect that occurs in subwavelength waveguide gratings. When these sensors are illuminated with a light source, a specific wavelength of light is reflected at a particular angle. Interaction of a target analyte with a biochemical layer on the sensor surface yields measurable spectral or angular shifts that directly identify the binding event.

RSVP or call (817) 735-5147 to reserve a seat.